Stock Events

Stock Events

Viracta Therapeutics (VIRX) Q2 2024 Earnings

9MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.35

-0.31

-0.27

-0.23

Details

Expected EPS

-0.3525

Actual EPS

-0.23

Surprise EPS

0.12

Surprise Percent

+34.75%

Description

Viracta Therapeutics (VIRX) has reported earnings of -0.23 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.